Global Non-invasive Parenteral Screening Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15124148 | Publishing Date : 24-Jan-2020 | No. of pages : 92
Detailed TOC of Global Non-invasive Parenteral Screening Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non-invasive Parenteral Screening Revenue
1.4 Market Analysis by Type
1.4.1 Global Non-invasive Parenteral Screening Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Instruments
1.4.3 Consumables
1.5 Market by Application
1.5.1 Global Non-invasive Parenteral Screening Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Laboratories
1.5.3 Hospitals
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Non-invasive Parenteral Screening Market Perspective (2015-2026)
2.2 Non-invasive Parenteral Screening Growth Trends by Regions
2.2.1 Non-invasive Parenteral Screening Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-invasive Parenteral Screening Historic Market Share by Regions (2015-2020)
2.2.3 Non-invasive Parenteral Screening Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Non-invasive Parenteral Screening Market Growth Strategy
2.3.6 Primary Interviews with Key Non-invasive Parenteral Screening Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Non-invasive Parenteral Screening Players by Market Size
3.1.1 Global Top Non-invasive Parenteral Screening Players by Revenue (2015-2020)
3.1.2 Global Non-invasive Parenteral Screening Revenue Market Share by Players (2015-2020)
3.1.3 Global Non-invasive Parenteral Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non-invasive Parenteral Screening Market Concentration Ratio
3.2.1 Global Non-invasive Parenteral Screening Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Revenue in 2019
3.3 Non-invasive Parenteral Screening Key Players Head office and Area Served
3.4 Key Players Non-invasive Parenteral Screening Product Solution and Service
3.5 Date of Enter into Non-invasive Parenteral Screening Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Non-invasive Parenteral Screening Historic Market Size by Type (2015-2020)
4.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2021-2026)
5 Non-invasive Parenteral Screening Breakdown Data by Application (2015-2026)
5.1 Global Non-invasive Parenteral Screening Market Size by Application (2015-2020)
5.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Non-invasive Parenteral Screening Market Size (2015-2020)
6.2 Non-invasive Parenteral Screening Key Players in North America (2019-2020)
6.3 North America Non-invasive Parenteral Screening Market Size by Type (2015-2020)
6.4 North America Non-invasive Parenteral Screening Market Size by Application (2015-2020)
7 Europe
7.1 Europe Non-invasive Parenteral Screening Market Size (2015-2020)
7.2 Non-invasive Parenteral Screening Key Players in Europe (2019-2020)
7.3 Europe Non-invasive Parenteral Screening Market Size by Type (2015-2020)
7.4 Europe Non-invasive Parenteral Screening Market Size by Application (2015-2020)
8 China
8.1 China Non-invasive Parenteral Screening Market Size (2015-2020)
8.2 Non-invasive Parenteral Screening Key Players in China (2019-2020)
8.3 China Non-invasive Parenteral Screening Market Size by Type (2015-2020)
8.4 China Non-invasive Parenteral Screening Market Size by Application (2015-2020)
9 Japan
9.1 Japan Non-invasive Parenteral Screening Market Size (2015-2020)
9.2 Non-invasive Parenteral Screening Key Players in Japan (2019-2020)
9.3 Japan Non-invasive Parenteral Screening Market Size by Type (2015-2020)
9.4 Japan Non-invasive Parenteral Screening Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Non-invasive Parenteral Screening Market Size (2015-2020)
10.2 Non-invasive Parenteral Screening Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Non-invasive Parenteral Screening Market Size by Type (2015-2020)
10.4 Southeast Asia Non-invasive Parenteral Screening Market Size by Application (2015-2020)
11 India
11.1 India Non-invasive Parenteral Screening Market Size (2015-2020)
11.2 Non-invasive Parenteral Screening Key Players in India (2019-2020)
11.3 India Non-invasive Parenteral Screening Market Size by Type (2015-2020)
11.4 India Non-invasive Parenteral Screening Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Non-invasive Parenteral Screening Market Size (2015-2020)
12.2 Non-invasive Parenteral Screening Key Players in Central & South America (2019-2020)
12.3 Central & South America Non-invasive Parenteral Screening Market Size by Type (2015-2020)
12.4 Central & South America Non-invasive Parenteral Screening Market Size by Application (2015-2020)
13Key Players Profiles
13.1 GE Healthcare
13.1.1 GE Healthcare Company Details
13.1.2 GE Healthcare Business Overview and Its Total Revenue
13.1.3 GE Healthcare Non-invasive Parenteral Screening Introduction
13.1.4 GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2015-2020))
13.1.5 GE Healthcare Recent Development
13.2 Philips
13.2.1 Philips Company Details
13.2.2 Philips Business Overview and Its Total Revenue
13.2.3 Philips Non-invasive Parenteral Screening Introduction
13.2.4 Philips Revenue in Non-invasive Parenteral Screening Business (2015-2020)
13.2.5 Philips Recent Development
13.3 Illumina
13.3.1 Illumina Company Details
13.3.2 Illumina Business Overview and Its Total Revenue
13.3.3 Illumina Non-invasive Parenteral Screening Introduction
13.3.4 Illumina Revenue in Non-invasive Parenteral Screening Business (2015-2020)
13.3.5 Illumina Recent Development
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Details
13.4.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Introduction
13.4.4 Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2015-2020)
13.4.5 Thermo Fisher Scientific Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview and Its Total Revenue
13.5.3 Roche Non-invasive Parenteral Screening Introduction
13.5.4 Roche Revenue in Non-invasive Parenteral Screening Business (2015-2020)
13.5.5 Roche Recent Development
13.6 PacBio
13.6.1 PacBio Company Details
13.6.2 PacBio Business Overview and Its Total Revenue
13.6.3 PacBio Non-invasive Parenteral Screening Introduction
13.6.4 PacBio Revenue in Non-invasive Parenteral Screening Business (2015-2020)
13.6.5 PacBio Recent Development
13.7 Perkinelmer
13.7.1 Perkinelmer Company Details
13.7.2 Perkinelmer Business Overview and Its Total Revenue
13.7.3 Perkinelmer Non-invasive Parenteral Screening Introduction
13.7.4 Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2015-2020)
13.7.5 Perkinelmer Recent Development
13.8 Qiagen
13.8.1 Qiagen Company Details
13.8.2 Qiagen Business Overview and Its Total Revenue
13.8.3 Qiagen Non-invasive Parenteral Screening Introduction
13.8.4 Qiagen Revenue in Non-invasive Parenteral Screening Business (2015-2020)
13.8.5 Qiagen Recent Development
13.9 Agilent Technologies
13.9.1 Agilent Technologies Company Details
13.9.2 Agilent Technologies Business Overview and Its Total Revenue
13.9.3 Agilent Technologies Non-invasive Parenteral Screening Introduction
13.9.4 Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2015-2020)
13.9.5 Agilent Technologies Recent Development
13.10 BGI Group
13.10.1 BGI Group Company Details
13.10.2 BGI Group Business Overview and Its Total Revenue
13.10.3 BGI Group Non-invasive Parenteral Screening Introduction
13.10.4 BGI Group Revenue in Non-invasive Parenteral Screening Business (2015-2020)
13.10.5 BGI Group Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Non-invasive Parenteral Screening Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Non-invasive Parenteral Screening Key Market Segments
Table 2. Key Players Covered: Ranking by Non-invasive Parenteral Screening Revenue
Table 3. Ranking of Global Top Non-invasive Parenteral Screening Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Non-invasive Parenteral Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Instruments
Table 6. Key Players of Consumables
Table 7. Global Non-invasive Parenteral Screening Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Non-invasive Parenteral Screening Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Non-invasive Parenteral Screening Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Non-invasive Parenteral Screening Market Share by Regions (2015-2020)
Table 11. Global Non-invasive Parenteral Screening Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Non-invasive Parenteral Screening Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Non-invasive Parenteral Screening Market Growth Strategy
Table 17. Main Points Interviewed from Key Non-invasive Parenteral Screening Players
Table 18. Global Non-invasive Parenteral Screening Revenue by Players (2015-2020) (Million US$)
Table 19. Global Non-invasive Parenteral Screening Market Share by Players (2015-2020)
Table 20. Global Top Non-invasive Parenteral Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-invasive Parenteral Screening as of 2019)
Table 21. Global Non-invasive Parenteral Screening by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Non-invasive Parenteral Screening Product Solution and Service
Table 24. Date of Enter into Non-invasive Parenteral Screening Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-invasive Parenteral Screening Market Size by Type (2015-2020) (Million US$)
Table 27. Global Non-invasive Parenteral Screening Market Size Share by Type (2015-2020)
Table 28. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2021-2026)
Table 29. Global Non-invasive Parenteral Screening Market Size Share by Application (2015-2020)
Table 30. Global Non-invasive Parenteral Screening Market Size by Application (2015-2020) (Million US$)
Table 31. Global Non-invasive Parenteral Screening Market Size Share by Application (2021-2026)
Table 32. North America Key Players Non-invasive Parenteral Screening Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Non-invasive Parenteral Screening Market Share (2019-2020)
Table 34. North America Non-invasive Parenteral Screening Market Size by Type (2015-2020) (Million US$)
Table 35. North America Non-invasive Parenteral Screening Market Share by Type (2015-2020)
Table 36. North America Non-invasive Parenteral Screening Market Size by Application (2015-2020) (Million US$)
Table 37. North America Non-invasive Parenteral Screening Market Share by Application (2015-2020)
Table 38. Europe Key Players Non-invasive Parenteral Screening Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Non-invasive Parenteral Screening Market Share (2019-2020)
Table 40. Europe Non-invasive Parenteral Screening Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Non-invasive Parenteral Screening Market Share by Type (2015-2020)
Table 42. Europe Non-invasive Parenteral Screening Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Non-invasive Parenteral Screening Market Share by Application (2015-2020)
Table 44. China Key Players Non-invasive Parenteral Screening Revenue (2019-2020) (Million US$)
Table 45. China Key Players Non-invasive Parenteral Screening Market Share (2019-2020)
Table 46. China Non-invasive Parenteral Screening Market Size by Type (2015-2020) (Million US$)
Table 47. China Non-invasive Parenteral Screening Market Share by Type (2015-2020)
Table 48. China Non-invasive Parenteral Screening Market Size by Application (2015-2020) (Million US$)
Table 49. China Non-invasive Parenteral Screening Market Share by Application (2015-2020)
Table 50. Japan Key Players Non-invasive Parenteral Screening Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Non-invasive Parenteral Screening Market Share (2019-2020)
Table 52. Japan Non-invasive Parenteral Screening Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Non-invasive Parenteral Screening Market Share by Type (2015-2020)
Table 54. Japan Non-invasive Parenteral Screening Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Non-invasive Parenteral Screening Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Non-invasive Parenteral Screening Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Non-invasive Parenteral Screening Market Share (2019-2020)
Table 58. Southeast Asia Non-invasive Parenteral Screening Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Non-invasive Parenteral Screening Market Share by Type (2015-2020)
Table 60. Southeast Asia Non-invasive Parenteral Screening Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Non-invasive Parenteral Screening Market Share by Application (2015-2020)
Table 62. India Key Players Non-invasive Parenteral Screening Revenue (2019-2020) (Million US$)
Table 63. India Key Players Non-invasive Parenteral Screening Market Share (2019-2020)
Table 64. India Non-invasive Parenteral Screening Market Size by Type (2015-2020) (Million US$)
Table 65. India Non-invasive Parenteral Screening Market Share by Type (2015-2020)
Table 66. India Non-invasive Parenteral Screening Market Size by Application (2015-2020) (Million US$)
Table 67. India Non-invasive Parenteral Screening Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Non-invasive Parenteral Screening Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Non-invasive Parenteral Screening Market Share (2019-2020)
Table 70. Central & South America Non-invasive Parenteral Screening Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Non-invasive Parenteral Screening Market Share by Type (2015-2020)
Table 72. Central & South America Non-invasive Parenteral Screening Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Non-invasive Parenteral Screening Market Share by Application (2015-2020)
Table 74. GE Healthcare Company Details
Table 75. GE Healthcare Business Overview
Table 76. GE Healthcare Product
Table 77. GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2015-2020) (Million US$)
Table 78. GE Healthcare Recent Development
Table 79. Philips Company Details
Table 80. Philips Business Overview
Table 81. Philips Product
Table 82. Philips Revenue in Non-invasive Parenteral Screening Business (2015-2020) (Million US$)
Table 83. Philips Recent Development
Table 84. Illumina Company Details
Table 85. Illumina Business Overview
Table 86. Illumina Product
Table 87. Illumina Revenue in Non-invasive Parenteral Screening Business (2015-2020) (Million US$)
Table 88. Illumina Recent Development
Table 89. Thermo Fisher Scientific Company Details
Table 90. Thermo Fisher Scientific Business Overview
Table 91. Thermo Fisher Scientific Product
Table 92. Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2015-2020) (Million US$)
Table 93. Thermo Fisher Scientific Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Product
Table 97. Roche Revenue in Non-invasive Parenteral Screening Business (2015-2020) (Million US$)
Table 98. Roche Recent Development
Table 99. PacBio Company Details
Table 100. PacBio Business Overview
Table 101. PacBio Product
Table 102. PacBio Revenue in Non-invasive Parenteral Screening Business (2015-2020) (Million US$)
Table 103. PacBio Recent Development
Table 104. Perkinelmer Company Details
Table 105. Perkinelmer Business Overview
Table 106. Perkinelmer Product
Table 107. Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2015-2020) (Million US$)
Table 108. Perkinelmer Recent Development
Table 109. Qiagen Business Overview
Table 110. Qiagen Product
Table 111. Qiagen Company Details
Table 112. Qiagen Revenue in Non-invasive Parenteral Screening Business (2015-2020) (Million US$)
Table 113. Qiagen Recent Development
Table 114. Agilent Technologies Company Details
Table 115. Agilent Technologies Business Overview
Table 116. Agilent Technologies Product
Table 117. Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2015-2020) (Million US$)
Table 118. Agilent Technologies Recent Development
Table 119. BGI Group Company Details
Table 120. BGI Group Business Overview
Table 121. BGI Group Product
Table 122. BGI Group Revenue in Non-invasive Parenteral Screening Business (2015-2020) (Million US$)
Table 123. BGI Group Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-invasive Parenteral Screening Market Share by Type: 2020 VS 2026
Figure 2. Instruments Features
Figure 3. Consumables Features
Figure 4. Global Non-invasive Parenteral Screening Market Share by Application: 2020 VS 2026
Figure 5. Diagnostic Laboratories Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Non-invasive Parenteral Screening Report Years Considered
Figure 8. Global Non-invasive Parenteral Screening Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Non-invasive Parenteral Screening Market Share by Regions: 2020 VS 2026
Figure 10. Global Non-invasive Parenteral Screening Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Non-invasive Parenteral Screening Market Share by Players in 2019
Figure 13. Global Top Non-invasive Parenteral Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-invasive Parenteral Screening as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Non-invasive Parenteral Screening Revenue in 2019
Figure 15. North America Non-invasive Parenteral Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Non-invasive Parenteral Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Non-invasive Parenteral Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Non-invasive Parenteral Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Non-invasive Parenteral Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Non-invasive Parenteral Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Non-invasive Parenteral Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. GE Healthcare Revenue Growth Rate in Non-invasive Parenteral Screening Business (2015-2020)
Figure 24. Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Philips Revenue Growth Rate in Non-invasive Parenteral Screening Business (2015-2020)
Figure 26. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Illumina Revenue Growth Rate in Non-invasive Parenteral Screening Business (2015-2020)
Figure 28. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive Parenteral Screening Business (2015-2020)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in Non-invasive Parenteral Screening Business (2015-2020)
Figure 32. PacBio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. PacBio Revenue Growth Rate in Non-invasive Parenteral Screening Business (2015-2020)
Figure 34. Perkinelmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Perkinelmer Revenue Growth Rate in Non-invasive Parenteral Screening Business (2015-2020)
Figure 36. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Qiagen Revenue Growth Rate in Non-invasive Parenteral Screening Business (2015-2020)
Figure 38. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Agilent Technologies Revenue Growth Rate in Non-invasive Parenteral Screening Business (2015-2020)
Figure 40. BGI Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. BGI Group Revenue Growth Rate in Non-invasive Parenteral Screening Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Keyplayers in Global Non-invasive Parenteral Screening Market Size, Status and Forecast 2020-2026
GE HealthcarePhilips
Illumina
Thermo Fisher Scientific
Roche
PacBio
Perkinelmer
Qiagen
Agilent Technologies
BGI Group